Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,258 citations, 2017 year and green oa status.
1,258
Citations
2017
Year
green
OA Status